Leucocytosis

Biomarker

1 paper3 findings

  • Humans1

Associations

3

ICU length of stay

upin humans1

1 study
  1. Leucocytosis is associated with ICU length of stay in humans (15% longer ICU stay (exp 1.15, 95% CI 1.00 to 1.32)).

    “Additionally, leucocytosis was associated with a 15% longer ICU stay (exp 1.15, 95% CI 1.00 to 1.32, p=0.043), but not hospital LOS.”

    Humansischaemic stroke admitted to ICUn = 615

    Leucocytosis and outcomes in older ICU patients after ischaemic stroke: a binational multicentre cohort study

    BMJ neurology open1 Jul 2026

In-hospital mortality

upin humans1

1 study
  1. Leucocytosis predicts in-hospital mortality in humans (aOR 2.01, 95% CI 1.29 to 3.13).

    “and hospital mortality (aOR 2.01, 95% CI 1.29 to 3.13, p=0.002).”

    Humansischaemic stroke admitted to ICUn = 615

    Leucocytosis and outcomes in older ICU patients after ischaemic stroke: a binational multicentre cohort study

    BMJ neurology open1 Jul 2026

ICU mortality

upin humans1

1 study
  1. Leucocytosis predicts ICU mortality in humans (aOR 2.33, 95% CI 1.11 to 4.96).

    “Compared with a normal WCC, leucocytosis was an independent predictor of ICU mortality (adjusted odds ratio 2.33, 95% CI 1.11 to 4.96, p=0.026)”

    Humansischaemic stroke admitted to ICUn = 615

    Leucocytosis and outcomes in older ICU patients after ischaemic stroke: a binational multicentre cohort study

    BMJ neurology open1 Jul 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months